SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-033716
Filing Date
2011-06-02
Accepted
2011-06-02 16:09:33
Documents
2
Period of Report
2011-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v224784_8k.htm 8-K 33940
2 EXHIBIT 10.1 v224784_ex10-1.htm EX-10.1 61691
  Complete submission text file 0001144204-11-033716.txt   96818
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD
Type: 8-K | Act: 34 | File No.: 000-53963 | Film No.: 11888703
SIC: 2835 In Vitro & In Vivo Diagnostic Substances